These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26396191)

  • 1. Discovery of Immunodominant B Cell Epitopes within Surface Pneumococcal Virulence Proteins in Pediatric Patients with Invasive Pneumococcal Disease.
    Lagousi T; Routsias J; Piperi C; Tsakris A; Chrousos G; Theodoridou M; Spoulou V
    J Biol Chem; 2015 Nov; 290(46):27500-10. PubMed ID: 26396191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Protective Efficacy of Selected Immunodominant B-Cell Epitopes within Virulent Surface Proteins of Streptococcus pneumoniae.
    Papastamatiou T; Routsias JG; Koutsoni O; Dotsika E; Tsakris A; Spoulou V
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans.
    Khan MN; Pichichero ME
    Vaccine; 2012 Apr; 30(18):2900-7. PubMed ID: 22349524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome lambda-display library.
    Beghetto E; Gargano N; Ricci S; Garufi G; Peppoloni S; Montagnani F; Oggioni M; Pozzi G; Felici F
    FEMS Microbiol Lett; 2006 Sep; 262(1):14-21. PubMed ID: 16907734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children.
    Ren D; Almudevar AL; Pichichero ME
    Hum Vaccin Immunother; 2015; 11(2):489-97. PubMed ID: 25692218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new candidate epitope-based vaccine against PspA PhtD of
    Shafaghi M; Bahadori Z; Barzi SM; Afshari E; Madanchi H; Mousavi SF; Shabani AA
    Front Cell Infect Microbiol; 2023; 13():1271143. PubMed ID: 38035337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadly Reactive Human Monoclonal Antibodies Targeting the Pneumococcal Histidine Triad Protein Protect against Fatal Pneumococcal Infection.
    Huang J; Gingerich AD; Royer F; Paschall AV; Pena-Briseno A; Avci FY; Mousa JJ
    Infect Immun; 2021 Apr; 89(5):. PubMed ID: 33649050
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccine.
    Dorosti H; Eslami M; Negahdaripour M; Ghoshoon MB; Gholami A; Heidari R; Dehshahri A; Erfani N; Nezafat N; Ghasemi Y
    J Biomol Struct Dyn; 2019 Aug; 37(13):3524-3535. PubMed ID: 30634893
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of a human immunodominant B-cell epitope within the immunoglobulin A1 protease of Streptococcus pneumoniae.
    De Paolis F; Beghetto E; Spadoni A; Montagnani F; Felici F; Oggioni MR; Gargano N
    BMC Microbiol; 2007 Dec; 7():113. PubMed ID: 18088426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge.
    Ochs MM; Williams K; Sheung A; Lheritier P; Visan L; Rouleau N; Proust E; de Montfort A; Tang M; Mari K; Hopfer R; Gallichan S; Brookes RH
    Hum Vaccin Immunother; 2016 Nov; 12(11):2946-2952. PubMed ID: 27392182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies.
    Brookes RH; Ming M; Williams K; Hopfer R; Gurunathan S; Gallichan S; Tang M; Ochs MM
    Hum Vaccin Immunother; 2015; 11(7):1836-9. PubMed ID: 25912273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 T cell memory and antibody responses directed against the pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice.
    Khan MN; Pichichero ME
    Infect Immun; 2013 Oct; 81(10):3781-92. PubMed ID: 23897609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to elicit seroresponses to pneumococcal surface proteins (pneumococcal histidine triad D, pneumococcal choline-binding protein A, and serine proteinase precursor A) in children with pneumococcal bacteraemia.
    Hagerman A; Posfay-Barbe KM; Grillet S; Ochs MM; Brookes RH; Greenberg D; Givon-Lavi N; Dagan R; Siegrist CA
    Clin Microbiol Infect; 2012 Aug; 18(8):756-62. PubMed ID: 21851490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions to protection from Streptococcus pneumoniae infection using the monovalent recombinant protein vaccine candidates PcpA, PhtD, and PlyD1 in an infant murine model during challenge.
    Verhoeven D; Perry S; Pichichero ME
    Clin Vaccine Immunol; 2014 Aug; 21(8):1037-45. PubMed ID: 24850621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to pneumococcal surface proteins in children with community-acquired pneumonia: a distinct pattern of responses to pneumococcal choline-binding protein A.
    Posfay-Barbe KM; Galetto-Lacour A; Grillet S; Ochs MM; Brookes RH; Kraehenbuhl JD; Cevey-Macherel M; Gehri M; Gervaix A; Siegrist CA
    Clin Microbiol Infect; 2011 Aug; 17(8):1232-8. PubMed ID: 21040158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine.
    Bologa M; Kamtchoua T; Hopfer R; Sheng X; Hicks B; Bixler G; Hou V; Pehlic V; Yuan T; Gurunathan S
    Vaccine; 2012 Dec; 30(52):7461-8. PubMed ID: 23123106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling specific antibody responses to natural immunization to predict a correlate of protection against infection before commencing a clinical vaccine trial.
    Almudevar A; Pichichero ME
    Hum Vaccin Immunother; 2017 Oct; 13(10):2316-2321. PubMed ID: 28892455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of epitopes recognized by antibodies induced by immunization of mice with PspA and PspC.
    Vadesilho CF; Ferreira DM; Gordon SB; Briles DE; Moreno AT; Oliveira ML; Ho PL; Miyaji EN
    Clin Vaccine Immunol; 2014 Jul; 21(7):940-8. PubMed ID: 24807052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.
    Singh R; Singh S; Sharma PK; Singh UP; Briles DE; Hollingshead SK; Lillard JW
    PLoS One; 2010 Feb; 5(2):e9432. PubMed ID: 20195541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Various Vaccine Candidate Proteins in Clinical Isolates of
    Kawaguchiya M; Urushibara N; Aung MS; Shinagawa M; Takahashi S; Kobayashi N
    Pathogens; 2019 Sep; 8(4):. PubMed ID: 31554325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.